Keywords: آمینوپپتیداز P; Angioedema; Bradykinin; ACE inhibitors; ARBs (angiotensin receptor blockers); Dipeptidyl peptidase IV inhibitors; Neprilysin inhibitors; Icatibant; ACEi; Angiotensin-converting-enzyme inhibitor; ANP; A-type natriuretic peptide; APP; Aminopeptidase P; ARB;